Pharmacologic and pharmacometric studies of factors affecting the pharmacokinetics and pharmacodynamics of antibody drug conjugate anetumab ravtansine in patients with solid tumors.

Authors: Li Chen, Andrew T. Lucas, Julie Dumond, Aaron Scott Mansfield, Stephanie Lheureux, Anna Spreafico, Claire O’Connor, Beth A. Zamboni, Kashish Patel, Jeffery Moscow, William Zamboni

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e15024

Source: Full article

---

Abstract

e15024